Announcements Trials
Browse Landscape

Phase

Phase 2 163Phase 3 92Phase 1 28Phase 1/2 22Phase 4 20Phase NA 12Phase EARLY_PHASE1 7Phase 2/3 6

Status

Completed 3Withdrawn 2Terminated 2

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 7Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 7Ovarian Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasm, Residual 1Estrogen Receptor-positive Breast Cancer 1Endometrial Endometrioid Adenocarcinoma 1Brain Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Letrozole 7Fluorodeoxyglucose F18 7Magnetic Resonance Spectroscopy 5Blood Specimen Collection 5pembrolizumab 4atezolizumab 4Trastuzumab 4Oncolytic Virotherapy 4Bevacizumab 4palbociclib 3Saline Solution 3Fish Oils 3Docosahexaenoic Acids 3Denosumab 3Carboplatin 3Biopsy 3pertuzumab 2olaparib 2Vitamin D 2Vinorelbine 2Taxes 2Sentinel Lymph Node Biopsy 2Radiotherapy 2Positron-Emission Tomography 2Positron Emission Tomography Computed Tomography 2Paclitaxel 2Omacor 2Neoadjuvant Therapy 2Metformin 2Lapatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Breast Neoplasms × Letrozole × Clear all
NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT02538484 2023-07-17

Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed
24 enrolled
Breast

Breast Neoplasms

NCT04130152 2022-10-25

PROMETEO II

SOLTI Breast Cancer Research Group

Phase EARLY_PHASE1 Completed
22 enrolled
Breast

Breast Neoplasms, Neoplasm, Residual

NCT04102618 2022-08-15

AWARE-1

Oncolytics Biotech

Phase EARLY_PHASE1 Terminated
26 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04630210 2022-06-15

AteBrO

Universitaire Ziekenhuizen KU Leuven

Phase EARLY_PHASE1 Withdrawn
Breast

Breast Neoplasms

NCT00651976 2018-10-15

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

Vanderbilt-Ingram Cancer Center

Phase EARLY_PHASE1 Terminated
213 enrolled
Breast

Breast Neoplasms

NCT02802748 2018-09-20

Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)

SOLTI Breast Cancer Research Group

Phase EARLY_PHASE1 Completed
60 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡